User loginNavigation |
CategoriesEmergent BioSolutions Hosts Symposium for Biomedical Research ScholarsROCKVILLE, Md., Aug 24, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today hosted “Looking Beyond the Bench,” a symposium organized for doctoral students enrolled in the NIH-Oxford-Cambridge Scholars Program. The symposium featured Emergent executives, who, based on their extensive experience in the biopharmaceutical industry, provided insight on potential career paths awaiting biomedical researchers.
Submitted by admin on Mon, 08/30/2010 - 07:34. categories [ ]
Emergent BioSolutions to Acquire Trubion Pharmaceuticals
ROCKVILLE, Md., Aug 12, 2010 (BUSINESS WIRE) –
Submitted by admin on Thu, 08/19/2010 - 06:27. categories [ ]
Emergent Revises Upward 2010 Financial ForecastCompany anticipates total revenues of $275 to $300 million and net income of $40 to $50 million
Submitted by admin on Tue, 08/03/2010 - 10:35. categories [ ]
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing FacilityROCKVILLE, MD, July 16, 2010 – Emergent BioSolutions Inc.
Submitted by admin on Tue, 07/27/2010 - 12:39. categories [ ]
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThraxROCKVILLE, Md., Jul 14, 2010 Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale manufacturing of BioThrax(R) (Anthrax Vaccine Adsorbed) in Building 55. Building 55 is the company’s large-scale state-of-the-art vaccine manufacturing facility in Lansing, Michigan.
Submitted by admin on Thu, 07/15/2010 - 15:53. categories [ ]
Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign GovernmentsROCKVILLE, MD, June 24, 2010 – Emergent BioSolutions Inc.
Submitted by admin on Wed, 07/07/2010 - 12:00. categories [ ]
Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary AssemblyEmergent BioSolutions' senior management team, headed by Fuad El-Hibri, chairman and chief executive officer and Daniel J. Abdun-Nabi, president and chief operating officer, are hosting "Bioterrorism Prevention, Preparedness and Response," a forum uniquely organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA).
Submitted by admin on Tue, 05/11/2010 - 15:33. categories [ ]
Fuad El-Hibri Official Bio Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding Int
Submitted by admin on Mon, 03/15/2010 - 09:11. categories [ ]
October 9, 2008 - Farr Honors Former Santa Cruz MayorWASHINGTON, D.C. - R. Scott Kennedy, former mayor of Santa Cruz and co-founder of the city's Resource Center for Nonviolence, was presented with the 2008 El-Hibri Peace Education Prize. This prize, including a check for $10,000, is a joint effort between Nonviolence International, American University and the El-Hibri family.
Submitted by admin on Sat, 10/17/2009 - 16:16. categories [ ]
Lebanese CEO Sees Opportunity in Current CrisisDaily Star
Submitted by admin on Wed, 10/14/2009 - 12:12. categories [ ]
|
Category CloudTag CloudWho's new
Who's onlineThere are currently 0 users and 1 guest online.
Recent comments
|